Navigation Links
Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
Date:11/13/2008

BEDFORD, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the results of the Cervista HPV high-risk pivotal clinical trial. The Cervista HPV high-risk test is currently under review by the FDA in the U.S. and is expected to be launched in the European Union (EU) early in 2009. The clinical and analytical performance of Cervista HPV high-risk test results are scheduled to be presented at the European Research Organization on Genital Infection and Neoplasia (Eurogin) HPV conference in Nice, France on Saturday, November 15th 2008. Due to an early publication of the abstract by the conference organizers, Hologic has brought forward the release of this data.

The Cervista HPV high-risk test is designed to detect the 14 high-risk types of HPV that cause cancer. The proposed intended use of the test is as a general screen, in combination with cervical cytology (pap test), to help guide patient management for women 30 years of age or older, and as a triage for ASC-US cytology results to determine the need for referral to colposcopy. The trial enrolled over 4,000 women including more than 1,300 women with equivocal pap results called ASC-US, from 89 locations across the United States. Hologic is pleased to announce that the clinical trial met or exceeded all of the target end points. The results of the study were as follows:

-- 100% CIN3 detection and a corresponding negative predictive value of 100%. Patients with CIN3 are at the highest risk of developing cervical cancer.

-- The sensitivity of the test for CIN2+ was 92.8%,
'/>"/>

SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
2. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
3. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
4. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
5. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
6. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
7. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
8. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
10. Immunosyn Corporation Releases SF-1019 Study Results
11. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...ec. 3 Guidepoint Global, LLC , a leading primary...r Sleep Apnea Tracker, a monthly longitudinal data...ket share in the worldwide Sleep Apnea market. ,,...sage for 87 different Sleep Apnea mask brands sold...providers going back to January 2006. In the most...
(Date:12/3/2009)...Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC...ing and commercializing innovative small molecule ...s and cancer, today announced that it will host a ...8, 2009 at 11:00am Eastern Time (10:00am Central T...ata regarding its HDAC Program (PCI-24781) and its...
(Date:12/3/2009)..., Del., Dec. 3 ParagonRx, a Delaware-based compan...nd optimal medication use, will host a free webina...e on REMS - Risk Evaluation Mitigation Strategy - ...anagement. Dr. Gary Slatko, chief medical officer...ement programs, will lead the one-hour program beg...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2AirClic Mobile Business Solutions Clic for Bio Reference Laboratories Inc 49012 1AirClic Mobile Business Solutions Clic for Bio Reference Laboratories Inc 49012 2All Seven Members of RBC Life Sciences Board of Directors Were Re Elected During the Companys 2009 Annual Shareholders Meeting 49008 1All Seven Members of RBC Life Sciences Board of Directors Were Re Elected During the Companys 2009 Annual Shareholders Meeting 49008 2CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders 4599 1CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders 4599 2CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders 4599 3
...ed Survival Data for Ipilimumab to be Presented, ...MEDX ) announced today that nine clinical abstract...tibody, in melanoma are scheduled to be,the subjec...opean Society,for Medical Oncology (ESMO) being he... following abstracts will include updated one-year...
...A says: Wrong Question Asked. Wrong Children Studi...3 A Centers for Disease,Control and Prevention (C...etween the MMR vaccine and autism. The National Au...g to dispel the growing public concern over a,vacc... concerning design,and methodology., For years, p...
Other Medicine Technology:Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3CDC Misses Target With Flawed MMR/Autism Study 2
(Date:12/5/2009)...day announced the launch of International Solution... insurance plan which follows the acclaimed modula...ring customers the flexibility to add or remove a ...ets, International Solutions enables customers to ...offered in their country of residence. , ...
(Date:12/5/2009)...bines are popping up in the most unusual places, a... wine to keeping prisoners in jail! , ... have thought that your wine, water and vegetables...Fort Worth, Texas has announced a new line of turb...ing a technology developed to provide power for da...
(Date:12/4/2009)...tment Trust Inc. (NYSE: CRE ) ("Care" or the "C...rs has declared a dividend of $0.17 per share of c...22, 2009 to common shareholders of record on Decem...,, Care Investment Trust Inc. is a real estate inv...e-related real estate and commercial mortgage debt...
(Date:12/4/2009)...rive, Inc. has won the Patient,s Choice Award as t...ar vote conducted by the online website, www.weed... the SF Bay community has selected Medithrive as t...ijuana. ,, The rapid rise and popularity of Medi...ters to the consumer, provides a beautiful environ...
(Date:12/4/2009)...can Association of Homes and Services for the Agin...he Community Living and Supportive Services (CLASS...islation . The CLASS provisions are essential for ...ies and their caregivers. ,, We urge the Senate t... affordable to care for families and caregivers. ,...
Breaking Medicine News(10 mins):Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
...nal Toxicology Program (NTP), has produced strong ... chromium (chromium 6) causes cancer when it is c...omium compounds are often used in electroplating, ...veloped malignant tumors upon administration of th...
...low-dose tablet of aspirin daily to prevent blood ...cations such as pre-eclampsia. The review,...ound that taking aspirin had a 10 percent reduced ... aspirin appears to slightly increase the risk of ...
... today approved a proposed campaign to raise at le...st phase of UCSF Medical Center at Mission Bay. ...ated medical center to serve children, women and c... in 2014, the 865,000-plus-gross-square-foot hospi...
...tically monitored because not enough is known abou... group of scientists writing in todays British Med...ed foods which claim to improve health, quality of...g in popularity. Between January and April 2005 20...
...ever Limited (HLL) in Kodaikanal, a popular hill s..., traveled all the way to Bombay in western India ...ompanys share-holders to raise to raise the issues...nently its controversial thermometer plant at Koda...
...the California Department of Insurance and the Ora... fraud. These three are being accused of perf...ently billing more than $30 million to insurance c...ate insurance fraud scheme in which hundreds of pa...
Other Medicine News:Health News:UC Regents Approve Fundraised Campaign for UCSF Medical Center at Mission Bay 2Health News:Functional Foods Must Be Monitored to Assess Their Long-term Safety and Effectiveness 2Health News:Poisoned Workers of Hindustan Lever Demand Treatment 2Health News:Poisoned Workers of Hindustan Lever Demand Treatment 3Health News:Poisoned Workers of Hindustan Lever Demand Treatment 4Health News:Rent-A Body Scam Busted 2Health News:Rent-A Body Scam Busted 3
...atchet design provides fingertip ratchet disengage...e Series I Instrument program offers state-of-the-...ile, while maintaining strength and durability. Lo...n tight joint spaces. Series I instruments are ava...
...atchet design provides fingertip ratchet disengage...e Series I Instrument program offers state-of-the-...ile, while maintaining strength and durability. Lo...n tight joint spaces. Series I instruments are ava...
Graspers Atraumatic
Basket Punches 90 Rotary
Medicine Products: